CE/CME Statement

Intended Audience

This activity was developed for neurologists and other Parkinson's disease (PD) specialists, including all health care professionals who care for patients with PD, who have an interest in the most current research on the diagnosis and treatment of PD and other movement disorders. 

Learning Objectives

At the conclusion of this activity, participants should be better able to:

  • Assess evolving theories of the pathophysiology/neurobiology of PD and other movement disorders
  • Incorporate strategies for the early, accurate diagnosis of PD
  • Describe therapeutic interventions currently available to manage motor fluctuations and dyskinesias
  • Cite the data of emerging therapies for the treatment of PD


Robert A. Hauser, MD, MBA
Professor of Neurobiology, Molecular Pharmacology and Physiology
Director, USF Health Byrd Parkinson's Disease and 
Movement Disorders Center of Excellence
National Parkinson Foundation Center of Excellence
University of South Florida
Tampa, Florida

Accreditation and Certification

The Annenberg Center for Health Sciences at Eisenhower is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

The Annenberg Center for Health Sciences at Eisenhower designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Disclosure Statement

It is the policy of the Annenberg Center for Health Sciences to ensure fair balance, independence, objectivity, and scientific rigor in all programming. All faculty and planners participating in sponsored programs are expected to identify and reference off-label product use and disclose any relationship with those supporting the activity or any others with products or services available within the scope of the topic being discussed in the educational presentation.

The Annenberg Center for Health Sciences assesses conflict of interest with its instructors, planners, managers, and other individuals who are in a position to control the content of CE/CME activities. All relevant conflicts of interest that are identified are thoroughly vetted by the Annenberg Center for fair balance, scientific objectivity of studies utilized in this activity, and patient care recommendations. The Annenberg Center is committed to providing its learners with high-quality CE/CME activities and related materials that promote improvements or quality in health care and not a specific proprietary business interest of a commercial interest.

In accordance with the Accreditation Council for Continuing Medical Education Standards, parallel documents from other accrediting bodies, and Annenberg Center for Health Sciences policy, the following disclosures have been made:

Robert A. Hauser, MD, MBA


Auspex Pharmaceuticals, Gerson Lehrmen Group (GLG), Allergan, AbbVie, Eli Lilly and Company, Impax Laboratories, Michael J. Fox Foundation, Teva Pharmaceuticals, UCB BioSciences, Inc. 
Speakers BureauBiotie Therapies, Novartis, Teva Pharmaceuticals, UCB BioSciences, Inc. 
Advisory BoardAcorda Therapeutics, Acadia Pharmaceuticals, AstraZeneca, Lundbeck Pharmaceuticals, Neurocrine Biosciences, Pfizer, Inc. 

The faculty for this activity has disclosed that there will be discussion about the use of products for non-FDA approved indications.

Additional content planners
The following have no significant relationship to disclose.
Linda Peckel (medical writer)
Nancy Monson (medical writer)
Andrew McCrea, PhD (peer reviewer)

Annenberg Center for Health Sciences
John Bayliss, VP, Business Development, spouse is an employee of Amgen, Inc; all other staff at the Annenberg Center for Health Sciences at Eisenhower have no relevant commercial relationships to disclose.

The ideas and opinions presented in this educational activity are those of the faculty and do not necessarily reflect the views of the Annenberg Center and/or its agents. As in all educational activities, we encourage practitioners to use their own judgment in treating and addressing the needs of each individual patient, taking into account that patient’s unique clinical situation. The Annenberg Center disclaims all liability and cannot be held responsible for any problems that may arise from participating in this activity or following treatment recommendations presented.

This activity is supported by an independent educational grant from AbbVie. 

This activity is an online enduring material. Successful completion is achieved by reading and viewing the material, reflecting on its implications in your practice, and completing the assessment component.

The estimated time to complete the activity is 1 hour.

Our Policy on Privacy

Annenberg Center for Health Sciences respects your privacy. We don’t share information you give us, or have the need to share this information in the normal course of providing the services and information you may request. If there should be a need or request to share this information, we will do so only with your explicit permission. See Privacy Statement and other information at http://www.annenberg.net/privacy-policy/

Contact Information

For help or questions about this Internet activity please contact Continuing Education:
Annenberg Center for Health Sciences
39000 Bob Hope Drive 
Dinah Shore Building
Rancho Mirage, CA 92270
Phone    760-773-4500
Fax    760-773-4513
8 AM – 5 PM, Pacific Time, Monday – Friday